abstract |
Procedure for selecting a therapeutic agent for diseases related to immunity such as allergy, autoimmune diseases, GvH and transplant rejection, comprising the steps of contacting DOCK2 or a SH3 domain thereof, ELMO or a domain of the terminal C thereof and a test substance, and then estimating the level of formation of the association of DOCK2 or the SH3 domain thereof and ELMO or the domain of terminal C thereof. |